iBio, Inc. IBIO
iBio, Inc. statistics & valuation
Market cap$83.0M
P / B5.6×
Net margin-4594.2%
Return on equity-123.5%
FCF margin-3830.0%
Return on capital-108.9%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | 38.3% | 57.1% | — | — | — | — |
| Operating margin | -4650.5% | -7392.9% | — | -1576.3% | -1312.1% | -854.9% | -782.4% | -3204.3% | -3622.8% | -1043.6% |
| Net margin | -4594.2% | -11069.8% | — | -2670.0% | -978.8% | -1003.6% | -871.8% | -3627.3% | -3688.3% | -1030.0% |
| FCF margin | -3830.0% | -8339.6% | — | -2378.5% | -1475.5% | -880.5% | -738.1% | -3246.4% | -3676.6% | -858.6% |
| Return on assets | -79.3% | -86.7% | -157.8% | -50.6% | -15.8% | -17.5% | -57.5% | -37.4% | -40.4% | -18.9% |
| Return on equity | -123.5% | -116.8% | -422.7% | -79.2% | -21.4% | -29.0% | -714.3% | -99.6% | -163.0% | -40.6% |
| Current ratio | 1.59 | 4.08 | 1.19 | 1.48 | 15.74 | 11.79 | 1.39 | 8.00 | 4.26 | 10.43 |
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.